Abstract
The recent cloning of a second estrogen receptor (ER), designated ERβ, has prompted a reevaluation of the role of ERs in breast cancer. We have developed and validated a real-time RT–PCR assay to quantify ERα and ERβ gene expression at the mRNA level in a series of 131 patients with unilateral invasive primary breast cancer. Although ERβ expression showed wide variations in tumor tissues, its range (nearly three orders of magnitude) was smaller than that of ERα (nearly four orders of magnitude), suggesting that ERβ is more tightly controlled than ERα. We observed a negative correlation between ERα and ERβ expression. ‘ERα-negative’ tumors (containing very low ERα mRNA levels) were associated with SBR histopathological grade III, RB1 underexpression and ERBB2 overexpression, confirming that ERα negativity delineates poorly differentiated tumors. The amount of ERα mRNA (but not that of ERβ mRNA) increased with age and was consequently higher in postmenopausal patients' tumors. Expression of ERα (but not that of ERβ) also correlated strongly with progesterone receptor (PR) and PS2 expression, suggesting that ERα has stronger transcriptional activity than ERβ towards genes containing an ERE (estrogen response element) in their promoters. Interestingly, we found a negative correlation between the expression of ERβ (but not ERα) and CCND1, which contains an AP1 element but not an ERE in its promoter. Taken together, these data confirm that ERα and ERβ play different roles in breast cancer, partly by mediating the transcription of various genes via different types of DNA enhancer. PR and PS2 seem to be mainly ERα-responsive genes, whereas CCND1 may be mainly ERβ-responsive. Our findings also underline the need for a reliable method, providing full range of quantitative values, to determine ERα and ERβ status in the clinical setting.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- ERα:
-
estrogen receptor alpha
- ERβ:
-
estrogen receptor beta
- PR:
-
progesterone receptor
- RT–PCR:
-
reverse transcriptase–polymerase chain reaction
- ERE:
-
estrogen response element
- RB1:
-
retinoblastoma gene
- E1A:
-
enzyme immunoassay
References
Bièche I, Laurendeau I, Tozlu S, Olivi M, Vidaud D, Lidereau R, Vidaud M . 1999a Cancer Res. 59: 2759–2765
Bièche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, Vidaud M . 1999b Clin. Chem. 45: 1148–1156
Bièche I, Lidereau R . 2000 Mol. Carcinog. 29: 151–158
Bloom HJG, Richardson WW . 1957 Br. J. Cancer 11: 359–377
Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang S, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, Cloutier T, Kuo W-L, Yaswen P Dairkee S, Giovanola J, Hutchinson GH, Isola J, /1 /2-/3, Palazzolo M, Martin C, Ericsson C, Pinkel D, Albertson D, Li W-B, Gray JW . 1998 Proc. Natl. Acad. Sci. USA 95: 8703–8708
Diab SG, Elledge RM, Clark GM . 2000 J. Natl. Cancer Inst. 92: 550–556
Dotzlaw H, Leygue E, Watson PH, Murphy LC . 1999 Cancer Res. 59: 529–532
EORTC Breast Cooperative Group revision . 1980 Eur. J. Cancer 16: 1513–1515
Fuqua SAW, Schiff R, Parra I, Friedrichs E, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM, Moore JT . 1999 Cancer Res. 59: 5425–5428
Gibson UEM, Heid CA, Wiiliams PM . 1996 Genome Res. 6: 995–1001
Group EBCTC . 1998 Lancet 351: 1451–1467
Järvinen TAH, Pelto-Huikko M, Holli K, Isola J . 2000 Am. J. Pathol. 156: 29–35
Jensen EV, Greene GL, DeSombre ER . 1987 Prog. Clin. Biol. Res. 249: 283–305
Kaplan EL, Meier P . 1958 J. Am. Stat. Assoc. 53: 457–481
Knowlden JM, Gee JMW, Robertson JFR, Ellis IO, Nicholson RI . 2000 Int. J. Cancer 89: 209–212
Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustaffson JA . 1996 Proc. Natl. Acad. Sci. USA 93: 5925–5930
Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA . 1997 Endocrinology 138: 863–870
Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S, Sonoo H . 2000 Clin. Cancer Res. 6: 512–518
Leygue E, Dotzlaw H, Watson PH, Murphy LC . 1998 Cancer Res. 58: 3197–3201
Mosselman S, Polman J, Dijkema R . 1996 FEBS Lett. 392: 49–53
Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson JA, Kushner PJ, Scanlan TS . 1997 Science 277: 1508–1510
Peto R, Pike MC, Armitage P . 1977 Br. J. Cancer 35: 1–39
Planas-Silva MD, Donaher JL, Weinberg RA . 1999 Cancer Res. 59: 4788–4792
Soubeyran I, Quénel N, Coindre JM, Bonichon F, Durand M, Wafflart J, Mauriac L . 1996 Br. J. Cancer 74: 1120–1125
Speirs V, Parkes AT, Kerin MJ, Walton DS, Carleton PJ, Fox JN, Atkin SL . 1999 Cancer Res. 59: 525–528
Acknowledgements
This work was supported by the Comité Régional des Hauts-de-Seine de la Ligue Nationale Contre le Cancer. We thank the staff of the Centre René Huguenin for their assistance in specimen collection and patient care.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bièche, I., Parfait, B., Laurendeau, I. et al. Quantification of estrogen receptor α and β expression in sporadic breast cancer. Oncogene 20, 8109–8115 (2001). https://doi.org/10.1038/sj.onc.1204917
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204917
Keywords
This article is cited by
-
Cytidine deaminase activity increases in the blood of breast cancer patients
Scientific Reports (2022)
-
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant
Breast Cancer Research (2021)
-
EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma
Scientific Reports (2020)
-
Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma
Scientific Reports (2019)
-
Cortical branched actin determines cell cycle progression
Cell Research (2019)